Kairos Pharma | 8-K: Current report
Kairos Pharma | 8-K: Current report
Kairos Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kairos Pharma | 8-K: Current report
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Officer Bhowmick Neil
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Director MAZANET ROSEMARY
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Officer Murali Ramachandran
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Director Keyoung Hansoo Michael
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Officer Samuelson Doug
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Officer Yu John S
Kairos Pharma | 3: Initial statement of beneficial ownership of securities-Director Bae Hyun W.
Kairos Pharma | 8-K: Current report
Kairos Pharma | 8-K: Current report
Kairos Pharma | 424B4: Prospectus
Kairos Pharma | EFFECT: Others
Kairos Pharma | CORRESP: CORRESP
Kairos Pharma | CORRESP: CORRESP
Kairos Pharma | CORRESP: CORRESP
Kairos Pharma | CERT: Others
Kairos Pharma | 8-A12B: Registration of a class of securities on a national securities exchange
No Data
No Data